Loading
Instead of paying per dose, a country would pay a fixed annual fee and treat every eligible patient with immunotherapy. This has worked for hepatitis C drugs and antibiotics.
Louisiana and Australia bought hepatitis C antivirals under subscription ('Netflix') models that delinked revenue from volume, and NHS England pays fixed annual subscriptions for two antibiotics. Checkpoint inhibitors are used across dozens of indications, are volume-limited in most middle-income countries by per-dose price, and have low marginal manufacturing cost. The proposal is a national subscription contract: a fixed annual payment for unlimited pembrolizumab or nivolumab (or a biosimilar once available) in all approved indications, with the manufacturer's incentive shifted to supporting diagnosis and appropriate use.
Shares The high price of anticancer drugs: origins, implications, barriers, solutions, Prices and value, Most of the world has almost no cancer care, Nivolumab.
Shares The high price of anticancer drugs: origins, implications, barriers, solutions, Prices and value, Nivolumab, Pembrolizumab.
Shares The high price of anticancer drugs: origins, implications, barriers, solutions, Prices and value, Most of the world has almost no cancer care.
Shares The high price of anticancer drugs: origins, implications, barriers, solutions, Prices and value, Most of the world has almost no cancer care.
Shares The high price of anticancer drugs: origins, implications, barriers, solutions, Prices and value, Most of the world has almost no cancer care.
Shares The high price of anticancer drugs: origins, implications, barriers, solutions, Prices and value, Nivolumab, Pembrolizumab.
Shares The high price of anticancer drugs: origins, implications, barriers, solutions, Prices and value, Nivolumab, Pembrolizumab.
Shares The high price of anticancer drugs: origins, implications, barriers, solutions, Prices and value.